89bio, Inc. (NASDAQ:ETNB – Get Rating) CEO Rohan Palekar sold 15,000 shares of the stock in a transaction dated Thursday, March 23rd. The stock was sold at an average price of $16.00, for a total transaction of $240,000.00. Following the sale, the chief executive officer now owns 269,080 shares of the company’s stock, valued at […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) – Equities researchers at HC Wainwright reduced their Q1 2023 EPS estimates for 89bio in a research report issued on Wednesday, March 22nd. HC Wainwright analyst E. Arce now forecasts that the company will earn ($0.53) per share for the quarter, down from their previous forecast of ($0.40). The […]
89bio (NASDAQ:ETNB – Get Rating) had its price objective increased by Raymond James from $25.00 to $50.00 in a report issued on Wednesday morning, The Fly reports. ETNB has been the topic of several other reports. Oppenheimer upped their price target on shares of 89bio from $12.00 to $18.00 and gave the company an outperform […]
89bio (NASDAQ:ETNB – Get Rating) had its target price boosted by Royal Bank of Canada from $27.00 to $36.00 in a report published on Wednesday, Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts also recently commented on ETNB. Oppenheimer upped their price objective on shares […]
89bio (NASDAQ:ETNB – Get Rating) had its target price hoisted by Cantor Fitzgerald from $34.00 to $45.00 in a research note issued to investors on Wednesday, The Fly reports. A number of other analysts have also recently weighed in on the company. Royal Bank of Canada restated an outperform rating and issued a $27.00 price […]